Evidence map›Paper›PMID 25393930›Full record

ArticleGenes and immunity

Balancing immunity and tolerance: genetic footprint of natural selection in the transcriptional regulatory region of HLA-G.

L Gineau, P Luisi, E C Castelli, J Milet, D Courtin, N Cagnin, B Patillon, H Laayouni, P Moreau, E A Donadi and 2 more

Open access · bronzeAbstract read
PubMed Publisher
In one paragraph

Article in Genes and immunity. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Population Genetics and Natural Selection in Rheumatic Disease.Rheumatic diseases clinics of North America · 2017
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 7 institutions in 3 countries.

L Gineau1] Institute of Research for Development, Mixed Research Unit 216 MERIT, Paris, France [2] Faculté de Pharmacie, Université Paris Descartes, Sorbonne Paris Cité, Paris, France.
P LuisiInstitute of Evolutionary Biology, CEXS-UPF-PRBB, Catalonia, Barcelona, Spain.
E C CastelliFaculdade de Medicina, UNESP-Univ Estatual Paulista, Departamento de Patologia, Botucatu, Brazil.
J MiletIRD, UMR 216, Centre d'Etude et de Recherche sur le Paludisme Associé à la Grossesse et à l'Enfance (CERPAGE); Faculté des Sciences de la Santé, Cotonou, Bénin.
D CourtinIRD, UMR 216, Centre d'Etude et de Recherche sur le Paludisme Associé à la Grossesse et à l'Enfance (CERPAGE); Faculté des Sciences de la Santé, Cotonou, Bénin.
N CagninDivision of Clinical Immunology, School of Medicine of Ribeirão Preto, University of São Paulo, São Paulo, Brazil.
B Patillon1] Institute of Research for Development, Mixed Research Unit 216 MERIT, Paris, France [2] Faculté de Pharmacie, Université Paris Descartes, Sorbonne Paris Cité, Paris, France [3] Université Paris Sud, Kremlin-Bicêtre, France.
H LaayouniInstitute of Evolutionary Biology, CEXS-UPF-PRBB, Catalonia, Barcelona, Spain.
P Moreau1] Commissariat à l'Energie Atomique et aux Energies Alternatives, institut des Maladies Emergentes et des Thérapies Innovantes, Service de Recherches en Hémato-Immunologie, Hôpital Saint-Louis, Paris, France [2] Université Paris Diderot, Sorbonne Paris Cité, UMR_E5, Institut Universitaire d'Hématologie, Hôpital Saint-Louis, Paris, France.
E A DonadiDivision of Clinical Immunology, School of Medicine of Ribeirão Preto, University of São Paulo, São Paulo, Brazil.
A Garcia1] Institute of Research for Development, Mixed Research Unit 216 MERIT, Paris, France [2] Faculté de Pharmacie, Université Paris Descartes, Sorbonne Paris Cité, Paris, France.
A Sabbagh1] Institute of Research for Development, Mixed Research Unit 216 MERIT, Paris, France [2] Faculté de Pharmacie, Université Paris Descartes, Sorbonne Paris Cité, Paris, France.
Institut de Biologia Evolutiva · ESUniversidade de São Paulo · BRUniversité Paris Cité · FRCommissariat à l'Énergie Atomique et aux Énergies Alternatives · FRDélégation Paris 5 · FRMère et Enfant en Milieu Tropical · FRUniversidade Estadual Paulista (Unesp) · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Human leukocyte antigen-G (HLA-G) has well-recognized immunosuppressive properties modulating the activity of many immune system cells, and polymorphisms observed at the HLA-G 5' upstream regulatory region (5'URR) may influence gene transcriptional regulation. In this study, we characterized the sequence variation and haplotype structure of the HLA-G 5'URR in worldwide populations to investigate the evolutionary history of the HLA-G promoter and shed some light into the mechanisms that may underlie HLA-G expression control. A 1.4-kb region, encompassing the known HLA-G regulatory elements, was sequenced in three African populations from Senegal, Benin and Congo, and data were combined with those available in the literature, resulting in a total of 1411 individuals from 21 worldwide populations. High levels of nucleotide and haplotype diversities, excess of intermediate-frequency variants and reduced population differentiation were observed at this locus when compared with the background genomic variation. These features support a strong molecular signature of balancing selection at HLA-G 5'URR, probably as a result of the competing needs to maintain both a maternal-fetal immune tolerance and an efficient host immune response to invading pathogens during human evolution. An extended analysis of a 300-kb region surrounding HLA-G revealed that this region is not involved in a hitchhiking effect and may be the direct target of selection.

Indexed as

Regulatory Elements, TranscriptionalSelection, GeneticGenetics, PopulationHaplotypesHLA-G AntigensHumansImmune ToleranceLinkage DisequilibriumPolymorphism, GeneticHLA-G Antigens

Identifiers

PMID25393930
OpenAlexW2068841492

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.